Aphexda
Aphexda (motixafortide) is a hematopoietic stem cell mobilizer. It's used to help move stem cells from the bone marrow to the blood to be collected and used for a stem cell transplant. This medication is specifically used for adults with multiple myeloma who will be getting a stem cell transplant. It's typically used together with filgrastim. Aphexda (motixafortide) is given as an injection under the skin by a healthcare professional before stem cells are collected. Side effects include injection site reactions, pain, flushing, and itching.
What is Aphexda (motixafortide)?
What is Aphexda (motixafortide) used for?
- Mobilizing (moving) stem cells into the blood for collection and use in stem cell transplant for people with multiple myeloma; used together with filgrastim
How Aphexda (motixafortide) works
Aphexda (motixafortide) is a hematopoietic stem cell mobilizer. More specifically, it's known as a C-X-C motif chemokine receptor 4 (CXCR4) inhibitor.
This medication helps your stem cells move from your bone marrow and into your blood. When the stem cells are in your blood, your healthcare team can collect your stem cells more easily. Once collected, the stem cells will be used for your stem cell transplant.
Drug facts
| Common Brands | Aphexda |
|---|---|
| Drug Class | Hematopoietic stem cell mobilizer |
| Controlled Substance Classification | Not a controlled medication |
| Generic Status | No lower-cost generic available |
| Availability | Prescription only |